Unofficial; not affiliated with the European Commission. Source: European Commission, EU Funding & Tenders Portal. Reused under the Commission's reuse policy (Decision 2011/833/EU, CC BY 4.0); we reorganise the facts and add counts.
Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers (HORIZON-MISS-2027-02-CANCER-02) is a forthcoming funding topic under Horizon Europe with a stated budget of €20 million. The next deadline is , 334 days away as of . It is planned to open on .
In our daily copy of EU Funding & Tenders Portal data (), 5 other topics in call HORIZON-MISS-2027-02 are listed; Horizon Europe has 376 open or forthcoming calls here; the median stated budget for Horizon Europe calls is €12 million; 107 Horizon Europe calls have a deadline in September 2027.
| Identifier | HORIZON-MISS-2027-02-CANCER-02 |
|---|---|
| Programme | Horizon Europe |
| Status | Forthcoming |
| Opening date | |
| Deadline | |
| Submission | Single-stage |
| Type of action | Horizon Europe Innovation Actions |
| Budget | €20 million (2027 budget) |
| Expected number of grants | 3 |
| EU contribution per project | €7 million to €10 million |
| Call | HORIZON-MISS-2027-02 — Supporting the implementation of the Cancer Mission |
| Themes on this site | Health, Digital and data |
| Cross-cutting priorities (portal) | Digital Agenda, Artificial Intelligence |
| Portal keywords | Anticancer therapy, Clinical medicine, Digital data, Gender in basic medicine, Personalised medicine, Radiology, nuclear medicine and medical imaging, Translational medicine, Cancer centre, Clinical Trial Centre, Comprehensive Cancer Centre |
Read the official topic page on the EU Funding & Tenders Portal
Type of action
Innovation actions fund activities closer to market, such as prototyping, testing, demonstration and piloting. They usually need a consortium of partners from several countries.
Deadline
Deadline as published: . Check the official page for the exact time and any changes; late submissions are not accepted.
Next steps
- Open the official topic page and read the conditions, the call document and the evaluation criteria.
- Create a free EU Login and register your organisation to get a PIC, if you do not have one.
- Find partners if the topic needs a consortium (the portal's partner search is free).
- Start a draft in the submission system from the topic page and submit before the deadline.
New to EU funding? Read how to apply for EU funding.
Related calls
- Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research — HORIZON-MISS-2027-02-CANCER-04, next deadline
- Leveraging functional genomics to reveal novel targets for cancer treatment — HORIZON-MISS-2027-02-CANCER-01, next deadline
- Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes — HORIZON-MISS-2027-02-CANCER-03, next deadline
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines — HORIZON-MISS-2027-02-CANCER-05, next deadline
- Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies — HORIZON-MISS-2027-02-CANCER-06, next deadline
- Biotechnology for Healthy Ageing — HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-02, next deadline
- Development of innovative tools, processes, equipment and technologies through responses to disasters and emergencies for search and rescue in hazardous conditions — HORIZON-CL3-2026-01-DRS-03, next deadline
- Multi-hazard approach and cumulative / cascading impacts — HORIZON-CL3-2026-01-DRS-02, next deadline
- Open topic on driving innovation uptake of disaster risk solutions — HORIZON-CL3-2026-01-DRS-04, next deadline
- Targeted innovative capabilities for the resilience of critical entities to natural and human-induced disasters, including hybrid scenarios — HORIZON-CL3-2026-01-INFRA-03, next deadline